JS

Joseph Swedish

Mesoblast Limited | Non-Executive Director, Non-Executive Chairman
Mr Swedish has more than two decades of healthcare leadership experience as the CEO for major United States healthcare enterprises. For 12 consecutive years, Modern Healthcare named Mr Swedish as one of the 100 Most Influential People in Healthcare, ranking in the top 20 of the health sector's most senior level executives, highlevel government administrators, elected officials, academics, and thought leaders for five consecutive years. Prior to joining Anthem, Mr. Swedish was CEO for several major integrated healthcare delivery systems.

Company and Roles

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Non-Executive Director
  • Non-Executive Chairman
5yrs, 10mthJun 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
10/01/24091,8851,327,077N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
10/01/24
Issued
827,077$0.285$235,716Issue of options
MSB
MSB
Mesoblast Limited
29/12/23
Buy
850$1.079$917On-market trade
MSB
MSB
Mesoblast Limited
28/12/23
Buy
91,035$1.088$99,082On-market trade
MSB
MSB
Mesoblast Limited
24/06/20
Issued
300,000$3.470$1,041,000Issue of options
MSB
MSB
Mesoblast Limited
31/12/18
Issued
200,000$1.160$232,000Issue of options.